ArticleScientific reports2025
Mean platelet volume as a biomarker of anemia and platelet disorders among metabolic syndrome patients in Northwest Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic syndrome (MetS) is associated with increased cardiovascular risk, and platelets play a significant role in its pathophysiology. Mean platelet volume (MPV) is a marker of platelet activity. This study investigates the relationship between MPV and hematological abnormalities in MetS patients in Northwest Ethiopia. A cross-sectional study was conducted on adult MetS patients at the University of Gondar Comprehensive Specialized Hospital. Data on hematological parameters, anthropometric measurements, and biochemical profiles were collected using standard procedures. Six milliliters of venous blood were taken to conduct hematological and biochemical analyses, using an automated hematology and chemistry analyzer, respectively. Spearman's rank correlation and Mann-Whitney U tests were used to analyze associations between MPV and other variables. Statistical significance was determined at P-value < 0.05. Weak positive correlations were found between MPV and RBC count (ρ = 0.1588, P = 0.0018), Hgb level (ρ = 0.1621, P = 0.0014), and Hct (ρ = 0.2119, P < 0.0001), while a moderate negative correlation was observed between MPV and platelet count (ρ = -0.3988, P < 0.0001). MetS patients with anemia exhibited significantly lower median MPV values, while those with thrombocytopenia showed significantly higher median MPV values. Conversely, patients with thrombocytosis had significantly lower median MPV values compared to those without thrombocytosis. MPV is associated with hematological abnormalities in MetS patients in Northwest Ethiopia. Lower MPV was found in anemic MetS patients, while higher MPV was linked to thrombocytopenia, suggesting MPV's potential as a marker for assessing platelet dysfunction in MetS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.